Colgate-Palmolive Company (CL)
This Consumer-Products Giant's Stock Is a Wall Street Top Pick for 2026
Morgan Stanley analysts named a consumer products giant known for its toothpaste one of their top picks for the year.
Colgate-Palmolive: Consistent Long-Term Execution Makes It Attractive
Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, currently trading at a reasonable 21.6x earnings. CL's science-based innovation and focus on high-growth categories and incremental product improvements, reinforcing its wide moat and market share, especially in oral care. Despite reduced guidance and sector headwinds, CL remains undervalued with a fair value estimate of $84.18 versus a ~$79 share price, supporting a buy rating.
Is Colgate's Productivity Program a Catalyst for Its Margins?
CL's productivity program is easing cost pressures and paving the way for mid-25% margins, balancing efficiency with brand investment.
4 Reasons Colgate-Palmolive Is a No-Brainer Hold Through 2027
Colgate-Palmolive NYSE: CL is a buy-and-hold quality stock offering significant incentives to consumer staples investors. The stock is trading at historically low valuations, pays a higher-than-average yield, can sustain its capital return, will grow its business in 2026, and buys back shares, to name a few.
Colgate-Palmolive Company (CL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Colgate-Palmolive Company (CL) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript
Colgate-Palmolive: Wide Moat And A Mispriced Future
Colgate-Palmolive (CL)'s diverse category system creates a deeper moat than its simple products suggest. It shows how shared chemistry, manufacturing flexibility and retail presence strengthen its competitive position. Hill's provides a stabilising demand pattern that supports the broader portfolio especially during slowdowns.
Colgate-Palmolive: This Dividend King Is Rebounding (Technical Analysis)
Colgate-Palmolive (CL) is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 Global Productivity Initiative and renewed focus on growth businesses. Technical analysis shows institutional accumulation, with positive momentum signals and a breakout above resistance on strong volume.
Is Colgate's Innovation Engine Enough to Revive Its Volumes?
CL bets on faster, science-led innovation and a global Colgate Total relaunch to overcome soft volumes and regain momentum.
GO vs. CL: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Grocery Outlet Holding Corp. (GO) or Colgate-Palmolive (CL). But which of these two stocks offers value investors a better bang for their buck right now?
CL Q3 Earnings Top Estimates, Favorable Currency Aids Organic Sales
Colgate's Q3 earnings beat estimates as pricing gains and favorable currency lift organic sales y/y despite soft volume trends.
Colgate-Palmolive (CL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) Surpasses Q3 Earnings Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.91 per share a year ago.
